Albert David Ltd

  • BSE Code : 524075
  • NSE Symbol : ALBERTDAVD
  • ISIN : INE155C01010
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 616.20 29.15(4.97%)

Open Price ()

605.00

Prev. Close ()

587.05

Volume (No’s)

4,954

Market Cap ()

351.85

Low Price ()

604.00

High Price ()

625.00

 

Board Meetings

Start Date End Date Purpose
02-Feb-2026 11-Feb-2026 Quarterly Results Albert David Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and approve To consider and approve Unaudited Financial Results for the third quarter and nine months ended 31st December 2025. To consider, approve and take on record the Unaudited Financial Results for the third quarter and nine months ended 31st December, 2025 (As Per BSE Announcement Dated on: 11/02/2026)
18-Dec-2025 18-Dec-2025 Board Meeting Outcome for Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Resignation Of Managing Director, CEO & Director
01-Nov-2025 12-Nov-2025 To consider, approve and take on record the Unaudited Financial Results of the Company for the Second Quarter and Half Year ended 30th September 2025 Unaudited Financial Results for quarter and half year ended 30th September 2025 In terms of Regulation 30, 33 and Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations') read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, we inform/submit that the Board of Directors in their meeting held today, i.e. November 12, 2025, have, inter-alia, considered, approved and taken on record the Unaudited Financial Results for the Quarter and Half Year ended September 30, 2025 and the Limited Review Report of the Auditors thereon and approve publication of the Results in the newspaper. (As Per BSE Announcement Dated on 12.11.2025)
25-Jul-2025 02-Aug-2025 Albert David Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2025 inter alia to consider and approve the Unaudited Financial Results of the Company for the First Quarter ended on 30th June 2025. Outcome of Board Meeting held on 02.08.2025 related to approval of unaudited Financial Results for 1st quarter ended 30th June, 2025, appointment of Dr. Rajiv Anant Desai (DIN:-11193975) as an Additional Director (Non -Executive Independent Director) w.e.f 02.08.2025 subject to approval of shareholders through postal ballot and approval of Postal ballot notice related to aforesaid appointment. (As Per BSE Announcement Dated on: 02/08/2025)
06-May-2025 13-May-2025 Albert David Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2025 inter alia to consider and approve Audited Financial Results For The Quarter And Year Ended March 31 2025 and Recommendation Of Dividend On Equity Shares for financial year ended March 31 2025. Outcome of Board Meeting dated 13.05.2025 Recommended Final Dividend at the rate of (50%) i.e Rs.5.00/- per share of Rs.10/- face value, for the financial year ended on March 31, 2025, subject to approval of the shareholders at the 86' Annual General Meeting of the Company (As Per BSE Announcement Dated on 13.05.2025)

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew